Capture the market for your drugs.
Let us use our creativity together to work out
successful registration strategies.
WE CAN HELP YOU IN HONG KONG,
HONDURAS, AND EVEN IN QUATAR.
Ever since the Thalidomide disaster of the late 1960s there has been a worldwide effort to increase drug safety via standardised registration procedures. Despite this drive for harmonization, registering a new drug is still an arduous task in many countries.
Legislation is only one of the problems. More frequently it is national idiosyncrasies that cause delays. It starts with language and continues to different cultural approaches and working procedures.
This is why PharmaLex has offices or contact partners in most EU countries. PharmaLex staff has a full command of the local language and know the ins and outs of national authorities. This means that we can react quickly when need be and anticipate potential problems. Naturally our offices in Asia and the USA can also be of assistance to you. PharmaLex has successfully compiled registration dossiers in more than 100 countries.
Europe-EU
- Austria
- Belgium
- Bulgaria
- Cyprus
- Denmark
- Finland
- France
- Germany
- Great Britain
- Greece
- Hungary
- Ireland
- Italy
- Luxemburg
- Netherlands
- Poland
- Portugal
- Rumania
- Slovakia
- Slovenia
- Spain
- Sweden
Europe - Non-EU
- Belarus
- Croatia
- Macedonia
- Norway
- Russia
- Switzerland
Latin America
- Argentina
- Bolivia
- Brazil
- Chile
- Columbia
- Costa Rica
- Cuba
- Dominican Republic
- Ecuador
- El Salvador
- Guatemala
- Haiti
- Honduras
- Mexiko
- Nicaragua
- Panama
- Peru
- Venezuela
Asia
- China
- Hong Kong
- India
- Indonesia
- Malaysia
- Pakistan
- Philippines
- Singapore
- Taiwan
- Thailand
- Vietnam
Middle East
- Bahrain
- Israel
- Yemen
- Jordan
- Kuwait
- Lebanon
- Oman
- Qatar
- Saudi Arabia
- Turkey
- United Arab Emirates
Africa
- South Africa
- Maghreb
- Egypt
- Rest of Africa
Oceania
- Australia
- New Zealand